APAC HBOT Devices Market

APAC HBOT Devices Market Size (2024 to 2029)

The size of the Hyperbaric Oxygen (HBO) Therapy Devices Market in the Asia Pacific is estimated to be worth USD 59.20 million by 2029 from USD 40.48 million in 2024. It is expected to grow at a CAGR of 7.9% from 2024 to 2029. It captures 20% of the global market.

The HBOT devices are used to treat chronic problem wounds caused by diabetes, venous or arterial insufficiency, crush injuries, and wounds/tissue damage induced by radiation therapy's late effects.  Chronic wounds play a significant financial and social burden on the person, the healthcare system, and society.

The significant rise in chronic and acute wounds and the growing popularity of leisure and adventure activities across the region are driving the HBOT devices market in the Asia Pacific. The increasing usage of hyperbaric oxygen therapy and the rising acceptance of the devices in emerging countries such as China and India boost the market growth. In addition, the advanced and ready availability of hyperbaric oxygen therapy systems will likely accelerate market growth. The leading players in the market are developing hyperbaric oxygen therapy, which is expected to boost market growth.

Furthermore, the technological advancements in the healthcare sector and the adoption of innovative products such as the development of portable hyperbaric oxygen therapy systems are supporting the market growth. The major companies in the region are increasing their investments and funds in research and development activities which is likely to offer significant growth opportunities for the market players. The market players implement the market strategies such as collaborations, mergers, and acquisitions to gain a competitive advantage over the marketplace. The increasing number of clinical trials sponsored by multiple universities and companies indicates that the APAC regional market is progressing correctly.

However, the high cost of treatment and limited awareness in rural areas in emerging countries limit the market growth. In addition, the lack of reimbursement policies in some parts of the region is hindering market growth. 

This research report on the APAC HBOT devices market has been segmented and sub-segmented into the following categories.

By Product:

• Monoplace HBOT Devices
• Multiplace HBOT Devices  
• Topical HBOT Devices        

By Application

• Wound Healing     
• Decompression Sickness   
• Infection Treatment           
• Gas Embolism        
• Others      

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Regionally, developing countries such as the Philippines, Vietnam, India, and China are experiencing strong economic growth in the APAC region. The growing population and growing need for wound healing treatment have driven the demand for HBOT in these regions. In addition, rising disposable income has shifted the consumer preference to avail of technologically advanced medical treatment and therapies. However, Asia Pacific is expected to be the fastest-growing region over the coming few years. This region is anticipated to deliver enormous growth due to increasing per capita income, the growing medical tourism industry, and raising public awareness regarding the benefits of HBOT devices. Compared to Japan's growth rate, China is anticipated to witness faster growth in the Asia Pacific region.

KEY MARKET PLAYERS:

Companies playing a vital role in the Asia Pacific HBOT devices market profiled in the market are HAUX-LIFE-SUPPORT; HEARMEC; IHC Hytech B.V. (Royal IHC); Hyperbaric SAC; Sechrist Industries, Inc.; Gulf Coast Hyperbarics, Inc.; Fink Engineering; ETC Hyperbaric Chambers (Environmental Tectonics Corporation);  OxyHeal International; and SOS Group Global Ltd.